Methylprednisolone Acetate Injection — FDA Drug Shortage

Current — Amneal Pharmaceuticals

The FDA lists a drug shortage record for Methylprednisolone Acetate Injection (injection) from Amneal Pharmaceuticals with status Current. The shortage was first posted on 12/15/2021.

Shortage Details

Status
Current
Company
Amneal Pharmaceuticals
Package NDC
70121-1574-5
Dosage Form
Injection
Presentation
Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 70121-1574-5)
Initial Posting
12/15/2021
Revised Date